Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Mesenchymal Stem Cell Therapy for Osteoradionecrosis of the Mandible: a Systematic Review of Preclinical and Human Studies

Publikation: Bidrag til tidsskriftReviewpeer review


  1. An In Vitro Differentiation Protocol for Human Embryonic Bipotential Gonad and Testis Cell Development

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Transient p53 suppression increases reprogramming of human fibroblasts without affecting apoptosis and DNA damage

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Mesenchymal stromal cell phenotype is not influenced by confluence during culture expansion

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Sequelae of Major Trauma Patients with Maxillofacial Fractures

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Osteoradionecrosis (ORN) of the mandible is a severe complication of radiotherapy for head and neck cancer and is arduously difficult to manage. Current treatment options carry risks with some patients remaining incurable. Mesenchymal stromal/stem cell (MSC) therapy has shown promising results supporting osteogenesis and regeneration of radiotherapy-damaged tissues. The aim of this study was to systematically review the literature on the safety and efficacy of MSCs in treating ORN.

METHODS: A systematic search was performed on MEDLINE, Embase, Cochranes Library online databases, and to identify preclinical and clinical studies examining the effect of MSCs on osseous healing of ORN. The preclinical studies were assessed according to the SYRCLEs guidelines and risk of bias tool.

RESULTS: Six studies (n = 142) from 5 countries were eligible for analysis. Of these four were preclinical studies and two clinical case studies. Preclinical studies found MSC treatment to be safe, demonstrating bone restorative effects and improved soft tissue regeneration. In the clinical cases, healing of bone and soft tissue was reported with no serious adverse events.

CONCLUSION: The evidence from the included studies suggests that MSCs may have beneficial regenerative effects on the healing of ORN. None of the studies reported adverse events with the use of MSCs. More carefully controlled studies with well-identified cells are however needed to demonstrate the efficacy of MSCs in a clinical setting. Graphical abstract.

TidsskriftStem Cell Reviews and Reports
Udgave nummer6
Sider (fra-til)1208-1221
Antal sider14
StatusUdgivet - dec. 2020

ID: 60788708